CN105343146A - Traditional Chinese medicine for bone coaptation - Google Patents
Traditional Chinese medicine for bone coaptation Download PDFInfo
- Publication number
- CN105343146A CN105343146A CN201510985399.8A CN201510985399A CN105343146A CN 105343146 A CN105343146 A CN 105343146A CN 201510985399 A CN201510985399 A CN 201510985399A CN 105343146 A CN105343146 A CN 105343146A
- Authority
- CN
- China
- Prior art keywords
- parts
- chinese medicine
- radix angelicae
- burtt
- hance
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/24—Heavy metals; Compounds thereof
- A61K33/26—Iron; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/11—Pteridophyta or Filicophyta (ferns)
- A61K36/12—Filicopsida or Pteridopsida
- A61K36/126—Drynaria
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/19—Acanthaceae (Acanthus family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/23—Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
- A61K36/232—Angelica
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/23—Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
- A61K36/237—Notopterygium
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/32—Burseraceae (Frankincense family)
- A61K36/324—Boswellia, e.g. frankincense
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/32—Burseraceae (Frankincense family)
- A61K36/328—Commiphora, e.g. mecca myrrh or balm of Gilead
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/906—Zingiberaceae (Ginger family)
- A61K36/9062—Alpinia, e.g. red ginger or galangal
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0014—Skin, i.e. galenical aspects of topical compositions
Abstract
The invention discloses a traditional Chinese medicine for bone coaptation. The traditional Chinese medicine comprises Chinese herbal medicinal ingredients in parts by weight as follows: 30-100 parts of Paraboea dictyoneura (Hance) B.L, Burtt, 30-100 parts of gendarussa vulgaris nees, 30-100 parts of calcined pyrite, 30-100 parts of fortune's drynaria rhizomes, 10-50 parts of teasel roots, 30-100 parts of dahurian angelica roots, 30-100 parts of pubescent angelica roots, 20-50 parts of Angelica sylvestris, 10-50 parts of frankincense and 10-50 parts of myrrh. During using, the Chinese herbal medicinal ingredients are firstly ground into powder, the powder is boiled with boiled water until the powder is pasty, a little rice wine is added, and then the product can be applied to the position of a fracture wound and is changed once every day. The traditional Chinese medicine for bone coaptation can have the treatment effects of detumescence, blood stasis removal, tendon relaxing, collateral activation, skeleton growth acceleration, short treatment course and the like and is more effective on fresh fracture, sprain and the like; through long-term clinical practice of fractures, the effective rate is 100%, and the cure rate is higher than 95%.
Description
Technical field
The present invention relates to field of medicine invention, more specifically relate to a kind of external medicine composition being used for the treatment of fracture.
Background technology
In daily life and work, fracture can be run into unavoidably, dislocate, or sprain, traumatic injury, the situation such as strain.When especially there is fracture, as the term suggests the structure being exactly head of phalanx or bone ruptures wholly or in part.Patient is often-individual position fracture, and minority is multiple fracture, and through appropriate process in time, most patient can recover original function, and a few patients can leave sequela in various degree.
Western medical treatment is treated by operative reduction, location, recovery from illness needs the time of about 3-6 month under normal circumstances, some patients even need the rehabilitation of 1 year ability, bring the long period painful to patient, moreover Post operation will use antibiotics to protect from infection, side effect is large, curative effect is slow, therapeutic effect is undesirable, makes troubles to the life of patient, too increases body burden and the financial burden of patient simultaneously.
Summary of the invention
Technical problem to be solved by this invention overcomes above-mentioned the deficiencies in the prior art, provides one to refute bone Chinese medicine, is intended to be better patient's reducing swelling and alleviating pain, accelerates skeleton growth, reduce treatment time, and expense is lower.
The technical scheme that the present invention solves the problems of the technologies described above employing is: one refutes bone Chinese medicine, comprises the Chinese medicine ingredients of following weight portion: Paraboea dictyoneura (Hance) B. L (Burtt) 30-100 part, little 30-100 part of reviving after death, Pyritum (calcined) 30-100 part, Rhizoma Drynariae 30-100 part, Radix Dipsaci 10-50 part, Radix Angelicae Dahuricae 30-100 part, Radix Angelicae Pubescentis 30-100 part, Rhizoma alpiniae chinensis 20-50 part, Olibanum 10-50 part and Myrrha 10-50 part.
Further, it also can preferably include the Chinese medicine ingredients of following weight portion: Paraboea dictyoneura (Hance) B. L (Burtt) 30-50 part, little 30-50 part of reviving after death, Pyritum (calcined) 30-50 part, Rhizoma Drynariae 30-50 part, Radix Dipsaci 10-30 part, Radix Angelicae Dahuricae 30-50 part, Radix Angelicae Pubescentis 30-50 part, Rhizoma alpiniae chinensis 20-30 part, Olibanum 10-30 part and Myrrha 10-30 part.
Further, it also can preferably include the Chinese medicine ingredients of following weight portion: Paraboea dictyoneura (Hance) B. L (Burtt) 30 parts, little revive after death 30 parts, Pyritum (calcined) 30 parts, Rhizoma Drynariae 30 parts, Radix Dipsaci 10 parts, the Radix Angelicae Dahuricae 30 parts, Radix Angelicae Pubescentis 30 parts, Rhizoma alpiniae chinensis 20 parts, Olibanum 10 parts and Myrrha 10 parts.
Further, it also can preferably include the Chinese medicine ingredients of following weight portion: Paraboea dictyoneura (Hance) B. L (Burtt) 50 parts, little revive after death 50 parts, Pyritum (calcined) 50 parts, Rhizoma Drynariae 50 parts, Radix Dipsaci 30 parts, the Radix Angelicae Dahuricae 50 parts, Radix Angelicae Pubescentis 50 parts, Rhizoma alpiniae chinensis 30 parts, Olibanum 30 parts and Myrrha 30 parts.
Further, it also can preferably include the Chinese medicine ingredients of following weight portion: Paraboea dictyoneura (Hance) B. L (Burtt) 100 parts, little revive after death 100 parts, Pyritum (calcined) 100 parts, Rhizoma Drynariae 100 parts, Radix Dipsaci 50 parts, the Radix Angelicae Dahuricae 100 parts, Radix Angelicae Pubescentis 100 parts, Rhizoma alpiniae chinensis 50 parts, Olibanum 50 parts and Myrrha 50 parts.
Further, it also can preferably include the Chinese medicine ingredients of following weight portion: Paraboea dictyoneura (Hance) B. L (Burtt) 65 parts, little revive after death 65 parts, Pyritum (calcined) 65 parts, Rhizoma Drynariae 65 parts, Radix Dipsaci 30 parts, the Radix Angelicae Dahuricae 65 parts, Radix Angelicae Pubescentis 65 parts, Rhizoma alpiniae chinensis 35 parts, Olibanum 30 parts and Myrrha 30 parts.
Using method of refuting bone Chinese medicine of the present invention is: first by above-mentioned Chinese medicine composition pulverize, boil with boiled water, until powder is cooked into pasty state, then adds a little rice wine, can spread on trauma fracture place, and every day its consumption change once.Good therapeutic effect can be reached, use very easy.
In theory of Chinese medical science: trauma fracture must cause meridians in body, vim and vigour and function disorderly, causes vim and vigour to fear wound, battalion defends internal organs discord, and meridians check, and bone marrow, periosteum and surrounding tissue and blood fortune are destroyed; Therefore, treatment should follow QI and blood regulating meridians, reducing swelling and alleviating pain, addiction of dispelling of invigorating blood circulation, simultaneously the agent of dual-purpose tonifying QI to promote blood circulation, passage, nourishing blood, thus reach the object of invigorating blood circulation addiction, fast reunion of fractured tendons and bones.In the present invention, above-mentioned each Chinese medicine ingredients has following primary treatment effect:
Paraboea dictyoneura (Hance) B. L (Burtt): taste is micro-sweet pungent, warm in nature, promoting blood circulation to remove blood stasis, reducing swelling and alleviating pain.
Littlely to revive after death: property is flat, lightly seasoned, promoting blood circulation to remove blood stasis.
Pyritum (calcined): pungent, flat, blood circulation promoting and blood stasis dispelling, pain relieving.
Rhizoma Drynariae: the kidney invigorating bone strengthening, continues and hinders pain relieving." Kaibao Bencao ": " main removing blood stasis, hemostasis are mended and traumaticd fracture ".
Radix Dipsaci: warm in nature, bitter in the mouth, pungent, there is effect of invigorating the liver and kidney, bone and muscle strengthening, continuous injured, only metrorrhagia, can be used for the disease for the treatment of soreness of the waist and knees, rheumatic arthralgia, metrorrhagia, vaginal bleeding during pregnancy, injury from falling down." herbal classic ": " main typhoid fever, tonifying for the deficiency, incised wound, carbuncle and ulcer, folding falls, reuniting the fractured tendons and bones ".
The Radix Angelicae Dahuricae: wind-damp dispelling, evacuation of pus of invigorating blood circulation, granulation promoting pain relieving." the southern regions of the Yunnan Province book on Chinese herbal medicine ": " wind of skin migration of dispelling, the only cold pain of the cold stomachache of stomach, whole body cold-damp pain ".
Radix Angelicae Pubescentis: calmness, hypnosis, analgesia, antiinflammatory action.
Rhizoma alpiniae chinensis: acrid, bitter, warm, induce sweat cold expelling, expelling wind and dampness, pain relieving.
Olibanum: this product has more significant analgesic activity, headed by Olibanum, the uterus ball of taste medicine antibacterially have stronger bacteriostasis than multiple, and effectively can kill infusorian." detailed outline ": " all poison of eliminating carbuncle cellulitis, the heart is protected in Tuoli, and analgesic therapy of invigorating blood circulation, stretches muscle, controls married woman's difficult labour, injured ".
Myrrha: loose blood blood stasis removing, subduing swelling and relieving pain.
Compared with prior art, beneficial effect of the present invention:
1. silt, relaxing muscles and tendons and activating QI and blood in the collateral are removed in detumescence;
2. fast, the short treating period of skeleton growth, coordinate health diet treatment time to be generally one and a half months to three month, expense is also low;
3. side effect is little, without the need to performing an operation, using antibiotics, can reduce patient pain largely;
4. pair fresh fracture, to sprain etc. more effective, clinical practice of fracturing through for a long time, effective percentage 100%, cure rate more than 95%.
Detailed description of the invention
Below in conjunction with specific embodiment, the present invention is described further.
Embodiment one:
The one of the present invention's design refutes bone Chinese medicine, and it specifically comprises the Chinese medicine ingredients of following weight portion: Paraboea dictyoneura (Hance) B. L (Burtt) 30 parts, little revive after death 30 parts, Pyritum (calcined) 30 parts, Rhizoma Drynariae 30 parts, Radix Dipsaci 10 parts, the Radix Angelicae Dahuricae 30 parts, Radix Angelicae Pubescentis 30 parts, Rhizoma alpiniae chinensis 20 parts, Olibanum 10 parts and Myrrha 10 parts.
Embodiment two:
The one of the present invention's design refutes bone Chinese medicine, and it specifically comprises the Chinese medicine ingredients of following weight portion: Paraboea dictyoneura (Hance) B. L (Burtt) 40 parts, little revive after death 40 parts, Pyritum (calcined) 40 parts, Rhizoma Drynariae 40 parts, Radix Dipsaci 20 parts, the Radix Angelicae Dahuricae 40 parts, Radix Angelicae Pubescentis 40 parts, Rhizoma alpiniae chinensis 25 parts, Olibanum 20 parts and Myrrha 20 parts.
Embodiment three:
The one of the present invention's design refutes bone Chinese medicine, and it specifically comprises the Chinese medicine ingredients of following weight portion: Paraboea dictyoneura (Hance) B. L (Burtt) 50 parts, little revive after death 50 parts, Pyritum (calcined) 50 parts, Rhizoma Drynariae 50 parts, Radix Dipsaci 30 parts, the Radix Angelicae Dahuricae 50 parts, Radix Angelicae Pubescentis 50 parts, Rhizoma alpiniae chinensis 30 parts, Olibanum 30 parts and Myrrha 30 parts.
Embodiment four:
The one of the present invention's design refutes bone Chinese medicine, and it specifically comprises the Chinese medicine ingredients of following weight portion: Paraboea dictyoneura (Hance) B. L (Burtt) 65 parts, little revive after death 65 parts, Pyritum (calcined) 65 parts, Rhizoma Drynariae 65 parts, Radix Dipsaci 30 parts, the Radix Angelicae Dahuricae 65 parts, Radix Angelicae Pubescentis 65 parts, Rhizoma alpiniae chinensis 35 parts, Olibanum 30 parts and Myrrha 30 parts.
Embodiment five:
The one of the present invention's design refutes bone Chinese medicine, and it specifically comprises the Chinese medicine ingredients of following weight portion: Paraboea dictyoneura (Hance) B. L (Burtt) 100 parts, little revive after death 100 parts, Pyritum (calcined) 100 parts, Rhizoma Drynariae 100 parts, Radix Dipsaci 50 parts, the Radix Angelicae Dahuricae 100 parts, Radix Angelicae Pubescentis 100 parts, Rhizoma alpiniae chinensis 50 parts, Olibanum 50 parts and Myrrha 50 parts.
Using method of refuting bone Chinese medicine of the present invention is: first by above-mentioned Chinese medicine composition pulverize, boil with boiled water, until powder is cooked into pasty state, then adds a little rice wine, can spread on trauma fracture place, and every day its consumption change once.Good therapeutic effect can be reached, use very easy.
Bone Chinese medicine of refuting of the present invention is on succession formula basis handed down from one's ancestors, revise, improve weak point, again in conjunction with distinct methods Comprehensive Treatment, fully demonstrate the feature of " organic conception and dialectical treat " of the traditional Chinese medical science for thousands of years, ideal therapeutic effect is achieved in Orthopedic Clinical treatment, particularly to the patient of fracture, there is unique curative effect.
The above, it is only preferred embodiment of the present invention, not any pro forma restriction is done to the present invention, any those skilled in the art, do not departing within the scope of technical solution of the present invention, the any brief introduction amendment done above embodiment according to technical spirit of the present invention, equivalent variations and modification, all still belong in the scope of technical solution of the present invention.
Claims (6)
1. refute bone Chinese medicine for one kind, it is characterized in that, comprise the Chinese medicine ingredients of following weight portion: Paraboea dictyoneura (Hance) B. L (Burtt) 30-100 part, little 30-100 part of reviving after death, Pyritum (calcined) 30-100 part, Rhizoma Drynariae 30-100 part, Radix Dipsaci 10-50 part, Radix Angelicae Dahuricae 30-100 part, Radix Angelicae Pubescentis 30-100 part, Rhizoma alpiniae chinensis 20-50 part, Olibanum 10-50 part and Myrrha 10-50 part.
2. according to claim 1ly refute bone Chinese medicine, it is characterized in that, comprise the Chinese medicine ingredients of following weight portion: Paraboea dictyoneura (Hance) B. L (Burtt) 30-50 part, little 30-50 part of reviving after death, Pyritum (calcined) 30-50 part, Rhizoma Drynariae 30-50 part, Radix Dipsaci 10-30 part, Radix Angelicae Dahuricae 30-50 part, Radix Angelicae Pubescentis 30-50 part, Rhizoma alpiniae chinensis 20-30 part, Olibanum 10-30 part and Myrrha 10-30 part.
3. according to claim 2ly refute bone Chinese medicine, it is characterized in that, comprise the Chinese medicine ingredients of following weight portion: Paraboea dictyoneura (Hance) B. L (Burtt) 30 parts, little revive after death 30 parts, Pyritum (calcined) 30 parts, Rhizoma Drynariae 30 parts, Radix Dipsaci 10 parts, the Radix Angelicae Dahuricae 30 parts, Radix Angelicae Pubescentis 30 parts, Rhizoma alpiniae chinensis 20 parts, Olibanum 10 parts and Myrrha 10 parts.
4. according to claim 2ly refute bone Chinese medicine, it is characterized in that, comprise the Chinese medicine ingredients of following weight portion: Paraboea dictyoneura (Hance) B. L (Burtt) 50 parts, little revive after death 50 parts, Pyritum (calcined) 50 parts, Rhizoma Drynariae 50 parts, Radix Dipsaci 30 parts, the Radix Angelicae Dahuricae 50 parts, Radix Angelicae Pubescentis 50 parts, Rhizoma alpiniae chinensis 30 parts, Olibanum 30 parts and Myrrha 30 parts.
5. according to claim 1ly refute bone Chinese medicine, it is characterized in that, comprise the Chinese medicine ingredients of following weight portion: Paraboea dictyoneura (Hance) B. L (Burtt) 100 parts, little revive after death 100 parts, Pyritum (calcined) 100 parts, Rhizoma Drynariae 100 parts, Radix Dipsaci 50 parts, the Radix Angelicae Dahuricae 100 parts, Radix Angelicae Pubescentis 100 parts, Rhizoma alpiniae chinensis 50 parts, Olibanum 50 parts and Myrrha 50 parts.
6. according to claim 1ly refute bone Chinese medicine, it is characterized in that, comprise the Chinese medicine ingredients of following weight portion: Paraboea dictyoneura (Hance) B. L (Burtt) 65 parts, little revive after death 65 parts, Pyritum (calcined) 65 parts, Rhizoma Drynariae 65 parts, Radix Dipsaci 30 parts, the Radix Angelicae Dahuricae 65 parts, Radix Angelicae Pubescentis 65 parts, Rhizoma alpiniae chinensis 35 parts, Olibanum 30 parts and Myrrha 30 parts.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201510985399.8A CN105343146A (en) | 2015-12-25 | 2015-12-25 | Traditional Chinese medicine for bone coaptation |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201510985399.8A CN105343146A (en) | 2015-12-25 | 2015-12-25 | Traditional Chinese medicine for bone coaptation |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN105343146A true CN105343146A (en) | 2016-02-24 |
Family
ID=55319306
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201510985399.8A Pending CN105343146A (en) | 2015-12-25 | 2015-12-25 | Traditional Chinese medicine for bone coaptation |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN105343146A (en) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN109620939A (en) * | 2019-02-27 | 2019-04-16 | 梁伯添 | A kind of anti-inflammatory antivirus composition, preparation method and applications |
Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101062233A (en) * | 2007-05-30 | 2007-10-31 | 姚绍刚 | Powdered medicine for coaptation and its preparing process |
| CN103505499A (en) * | 2013-01-09 | 2014-01-15 | 席安胜 | Fracture rapid healing plaster prescription |
-
2015
- 2015-12-25 CN CN201510985399.8A patent/CN105343146A/en active Pending
Patent Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101062233A (en) * | 2007-05-30 | 2007-10-31 | 姚绍刚 | Powdered medicine for coaptation and its preparing process |
| CN103505499A (en) * | 2013-01-09 | 2014-01-15 | 席安胜 | Fracture rapid healing plaster prescription |
Non-Patent Citations (1)
| Title |
|---|
| 杨济等主编: "《临证用药配伍指南》", 30 September 1996, 中国医药科技出版社 * |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN109620939A (en) * | 2019-02-27 | 2019-04-16 | 梁伯添 | A kind of anti-inflammatory antivirus composition, preparation method and applications |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN107095982A (en) | A kind of Tong,-a topical application of drug agent and preparation method thereof | |
| CN100446796C (en) | Externally applied pharmaceutical for bone fracture | |
| CN103263551A (en) | Powder for external use for relieving swelling and dispersing blood stasis | |
| CN104225478A (en) | Medicine for treating scapulohumeral periarthritis and preparation method thereof | |
| CN103768531B (en) | Chinese medicine composition being used for the treatment of rheumatoid arthritis and preparation method thereof | |
| CN105194351A (en) | Traditional Chinese medicine ointment for treating bone diseases | |
| CN105343146A (en) | Traditional Chinese medicine for bone coaptation | |
| CN104083568A (en) | Miao medicine plaster for ostealgia and preparation method thereof | |
| CN104161890A (en) | Traditional Chinese medicine granule for treating hyperostosis | |
| CN103230535A (en) | Medicinal liquor with function of activating collaterals to ease pain | |
| CN103585257B (en) | A kind of Chinese powder medicine for the treatment of fracture | |
| CN105497779A (en) | Traditional Chinese medicine patch for treating acute lumbar sprain | |
| CN109806351A (en) | Neck-shoulder pain, lumbago and leg pain temperature, which is applied, to be dissipated | |
| CN103494909B (en) | A kind of Chinese medicine composition for the treatment of comminuted bone injury | |
| CN104257967B (en) | A kind of Chinese medicine for treating injury gained in sports | |
| CN103251724A (en) | External plaster for treating bone injuries and preparation method thereof | |
| CN102018405B (en) | Medicine pillow for treating scapulohumeral periarthritis | |
| CN102614330A (en) | Medicinal liquor for treating rheumatic arthritis | |
| CN107551245A (en) | The special pharmaceutical composition of fiery pin, preparation method and its usage | |
| CN103127349B (en) | Medicine for treating traumatic injury | |
| CN105327276A (en) | External-use traditional Chinese medicine wine for treating acute lumbar sprain and preparation method of external-use traditional Chinese medicine wine | |
| CN112972572A (en) | Traditional Chinese medicine composition for treating arthritis, medicinal liquor and preparation method of medicinal liquor | |
| CN103330843B (en) | Medicinal liquor for treating postpartum rheumatism | |
| CN104173652B (en) | A kind of Chinese medicine composition for treating lumbar muscle strain | |
| CN103830409A (en) | Traditional Chinese medicine preparation for treating traumatic muscle stiffness and application method thereof |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| RJ01 | Rejection of invention patent application after publication | ||
| RJ01 | Rejection of invention patent application after publication |
Application publication date: 20160224 |